Expression Table for this CRE
| CNhs14498 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 44.1 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 7.2 |
| CNhs14492 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2 | 6.3 |
| CNhs12064 | Anulus Pulposus Cell, donor2 | 6.3 |
| CNhs13844 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 6.2 |
| CNhs14494 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1 | 6.0 |
| CNhs12377 | mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02) | 5.7 |
| CNhs14519 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1 | 5.4 |
| CNhs14497 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1 | 5.3 |
| CNhs12376 | mesenchymal precursor cell - ovarian cancer left ovary, donor3 | 4.8 |
| CNhs12654 | MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 4.3 |
| CNhs14491 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1 | 3.9 |
| CNhs14493 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 3.8 |
| CNhs12665 | MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 3.7 |
| CNhs12659 | MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 3.6 |
| CNhs12652 | MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2 | 3.5 |
| CNhs12660 | MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 3.5 |
| CNhs12954 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 3.4 |
| CNhs12375 | mesenchymal precursor cell - ovarian cancer right ovary, donor2 | 3.3 |
| CNhs12998 | testis, adult, pool2 | 3.0 |
| CNhs12379 | amniotic membrane cells, donor3 | 2.7 |
| CNhs13223 | CD4+CD25-CD45RA+ naive conventional T cells, donor1 | 2.6 |
| CNhs13843 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 2.6 |
| CNhs12656 | MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 2.6 |
| CNhs12398 | Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction) | 2.4 |
| CNhs13831 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 2.4 |
| CNhs12657 | MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 2.4 |
| CNhs14488 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 2.3 |
| CNhs12431 | MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1 | 2.3 |
| CNhs12435 | MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1 | 2.3 |
| CNhs12663 | MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 2.2 |
| CNhs12344 | Fibroblast - Choroid Plexus, donor2 | 2.2 |
| CNhs12085 | Bronchial Epithelial Cell, donor2 | 2.2 |
| CNhs12466 | K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1 | 2.2 |
| CNhs11717 | oral squamous cell carcinoma cell line:HSC-3 | 2.1 |
| CNhs12692 | K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2 | 2.1 |
| CNhs12734 | Fibroblast - Conjunctival, donor3 | 2.1 |
| CNhs12733 | Retinal Pigment Epithelial Cells, donor3 | 2.1 |
| CNhs12075 | Hepatic Sinusoidal Endothelial Cells, donor1 | 2.1 |
| CNhs11723 | leiomyoma cell line:15242A | 2.0 |
| CNhs11676 | uterus, adult, pool1 | 2.0 |
| CNhs11725 | argyrophil small cell carcinoma cell line:TC-YIK | 2.0 |
| CNhs11885 | small cell cervical cancer cell line:HCSC-1 | 2.0 |
| CNhs11677 | salivary gland, adult, pool1 | 2.0 |
| CNhs11722 | leiomyoma cell line:10964C | 1.9 |
| CNhs11715 | Hodgkin's lymphoma cell line:HD-Mar2 | 1.9 |
| CNhs12653 | MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2 | 1.9 |
| CNhs13444 | eye - muscle inferior rectus, donor1 | 1.8 |
| CNhs14573 | Myoblast differentiation to myotubes, day06, control donor2 | 1.8 |
| CNhs12594 | Mast cell, donor2 | 1.7 |